July 3, 2024 - July 5, 2024

Emcure Pharma IPO Review & Recommendations

Dilip Davda has given "Apply" recommendation to Emcure Pharma IPO.

Emcure Pharma IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	1	0	0	0	0
%	100.00	0.00	0.00	0.00	0.00

Emcure Pharma IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Apply

Emcure Pharma IPO Review by Dilip Davda (Apply)

[Dilip Davda] The company is one of the leading pharma company having niche products and serving global markets. It marked growth in its top lines, but bottom line posted declining trends due to higher interest and depreciation costs. Based on FY24 earnings, the issue appears fully priced. Reduction in debt post IPO will improved its bottom line commensurately. Investors may park funds for the medium to longer term. Read detail review...

Emcure Pharma IPO Peer Comparison

Emcure Pharmaceuticals Limited peer comparison with similar listed entities. (As on March 31, 2024)

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Emcure Pharmaceuticals Limited	27.54	27.54	163.22		21.27		Consolidated
Dr. Reddy's Laboratories Limited	335.22	335.59	1,693.75	17.93	19.74	3.54	Consolidated
Cipla Ltd.	51.05	51.01	330.78	30.10	15.43	4.64	Consolidated
Alkem Laboratories Ltd	150.19	150.19	862.46	33.86	17.41	5.90	Consolidated
Torrent Pharmaceuticals Ltd.	48.94	48.94	202.57	57.74	24.15	13.95	Consolidated
Mankind Pharma Limited	47.75	47.68	233.73	45.30	20.43	9.24	Consolidated
Abbott India Ltd.	565.28	565.28	1,740.71	47.43	32.48	15.40	Consolidated
J. B. Chemicals & Pharmaceuticals Limited	35.66	34.85	188.37	50.49	18.90	9.34	Consolidated

The financial information for Emcure Pharma is based on the Restated Consolidated Financial Statements as of and for the financial year ended March 31, 2024. The financial information for listed industry peers mentioned above, sourced from the audited financial statements of the respective companies for the financial year ended March 31, 2024, is on a consolidated basis (except for Abbott India Limited, where financial information is available only on a standalone basis) and is submitted to the Stock Exchanges.

Notes:

Basic and Diluted EPS for peers are sourced from the audited financial statements for the relevant year
The P/E Ratio has been computed based on the closing market price of equity shares on BSE Limited on June 21, 2024 divided by the Diluted EPS
For listed peers, RoNW is computed as profit attributable to company owners divided by Total Equity attributable to the owners of the Company as on March 31, 2024.
Net Asset Value ("NAV") is computed as the closing net worth divided by the equity shares outstanding as on March 31, 2024.

Emcure Pharma IPO Review by Members

Emcure Pharma IPO Reviews, analysis and views by popular members. Read Emcure Pharmaceuticals Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Emcure Pharma IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	2	0	0
%	0.00	100.00	0.00	0.00

Member	Review
Dhanvantri	May Apply for Long Term at Upper Price Band Borrowing 2000 crores much higher HIV Monopoly pharma co Price Band much higher nothing left for listing gain May Apply \| June 29, 2024 10:37:17 AM
Professōr Top Contributor (500+ Posts, 100+ Likes)	May Apply for Short Term at Cut-off Price No superb listing gains expected , decent returns will be there \| June 28, 2024 10:16:19 AM

Member

Review

Dhanvantri

May Apply for Long Term at Upper Price Band

Borrowing 2000 crores much higher HIV Monopoly pharma co Price Band much higher nothing left for listing gain May Apply

June 29, 2024 10:37:17 AM

Professōr

Top Contributor (500+ Posts, 100+ Likes)

May Apply for Short Term at Cut-off Price

No superb listing gains expected , decent returns will be there

June 28, 2024 10:16:19 AM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Comments

Add a public comment...